ストックスクリーナーアプリを入手
44.16
1.01%
-0.45
アフターアワーズ：
44.16
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat
Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com
Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire
Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by US Bancorp DE - Defense World
FDA Approves Amphastar's New Epinephrine Drug, Boosting Market Growth - openPR
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings - MSN
Amphastar Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by New York State Teachers Retirement System - Defense World
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of Stock - MarketBeat
William J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Amphastar Pharmaceuticals executive sells $271,388 in stock By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals executive sells $271,388 in stock - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 3.62% on Nov 8 - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownTime to Sell? - MarketBeat
Amphastar: Q3 Earnings Snapshot - Houston Chronicle
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - AccessWire
Amphastar Q3 Revenue Hits $191.2M; BAQSIMI Sales Shine as Board Boosts Buyback Program | AMPH Stock News - StockTitan
Hyaluronidase Market Set for Rapid Expansion (2024-2031): - openPR
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Pre - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to “Hold” at StockNews.com - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Hold Rating by StockNews.com - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Raymond James & Associates - Defense World
Allspring Global Investments Holdings LLC Trims Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
International Assets Investment Management LLC Buys Shares of 22,809 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Trend Tracker for (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals (AMPH) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024 - AccessWire
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Boston Trust Walden Corp Purchases Shares of 539,639 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now? - Yahoo Finance
Amphastar: Objectively Undervalued But For Good Reason (Rating Downgrade) (AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Moody Aldrich Partners LLC - MarketBeat
Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock - Simply Wall St
nVerses Capital LLC Buys 400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report? - MSN
(AMPH) Investment Report - Stock Traders Daily
GAMMA Investing LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Upgraded by StockNews.com - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by StockNews.com to “Buy” - Defense World
0.79%
0.15%
大文字化:
|
ボリューム (24 時間):